Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 31, 2026.

Imported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain

Stephan Günther, Petra Emmerich, Thomas Laue and 6 more

Emerging Infectious Diseases · 2000

doi:10.3201/eid0605.000504

Abstract

We describe the isolation and characterization of a new Lassa virus strain imported into Germany by a traveler who had visited Ghana, Côte D'Ivoire, and Burkina Faso. This strain, designated "AV," originated from a region in West Africa where Lassa fever has not been reported. Viral S RNA isolated from the patient's serum was amplified and sequenced. A long-range reverse transcription polymerase chain reaction allowed amplification of the full-length (3.4 kb) S RNA. The coding sequences of strain AV differed from those of all known Lassa prototype strains (Josiah, Nigeria, and LP) by approximately 20%, mainly at third codon positions. Phylogenetically, strain AV appears to be most closely related to strain Josiah from Sierra Leone. Lassa viruses comprise a group of genetically highly diverse strains, which has implications for vaccine development. The new method for full-length S RNA amplification may facilitate identification and molecular analysis of new arenaviruses or arenavirus strains.

References 40

  1. 1.

    Auperin D. D., McCormick J. B. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology. 1989;168(2):421-425.

    Not in our library10.1016/0042-6822(89)90287-0

  2. 2.

    Bowen M. D., Peters C. J., Nichol S. T. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol. 1997;8(3):301-316.

    Not in our library10.1006/mpev.1997.0436

  3. 3.

    Buchmeier M. J., Southern P. J., Parekh B. S., Wooddell M. K., Oldstone M. B. Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins. J Virol. 1987;61(4):982-985.

    Not in our library10.1128/jvi.61.4.982-985.1987

  4. 4.

    Buckley S. M., Casals J. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg. 1970;19(4):680-691.

    Not in our library10.4269/ajtmh.1970.19.680

  5. 5.

    Carey D. E., Kemp G. E., White H. A., Pinneo L., Addy R. F., Fom A. L., Stroh G., Casals J., Henderson B. E. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg. 1972;66(3):402-408.

    Not in our library10.1016/0035-9203(72)90271-4

  6. 6.

    Clegg J. C., Lloyd G. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet. 1987;2(8552):186-188.

    Not in our library10.1016/s0140-6736(87)90767-7

  7. 7.

    Clegg J. C., Wilson S. M., Oram J. D. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. Virus Res. 1991;18(2-3):151-164.

    Not in our library10.1016/0168-1702(91)90015-n

  8. 8.

    Demby A. H., Chamberlain J., Brown D. W., Clegg C. S. Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol. 1994;32(12):2898-2903.

    Not in our library10.1128/jcm.32.12.2898-2903.1994

  9. 9.

    Djavani M., Lukashevich I. S., Sanchez A., Nichol S. T., Salvato M. S. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. Virology. 1997;235(2):414-418.

    Not in our library10.1006/viro.1997.8722

  10. 10.

    Evans D. M., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 1985;314(6011):548-550.

    Not in our library10.1038/314548a0

  11. 11.

    Fisher-Hoch S. P., McCormick J. B., Auperin D., Brown B. G., Castor M., Perez G., Ruo S., Conaty A., Brammer L., Bauer S. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A. 1989;86(1):317-321.

    Not in our library10.1073/pnas.86.1.317

  12. 12.

    Frame J. D., Baldwin J. M., Gocke D. J., Troup J. M. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg. 1970;19(4):670-676.

    Not in our library10.4269/ajtmh.1970.19.670

  13. 13.

    Francis S. J., Southern P. J. Deleted viral RNAs and lymphocytic choriomeningitis virus persistence in vitro. J Gen Virol. 1988;69(Pt 8):1893-1902.

    Not in our library10.1099/0022-1317-69-8-1893

  14. 14.

    Günther S., Sommer G., Von Breunig F., Iwanska A., Kalinina T., Sterneck M., Will H. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol. 1998;36(2):531-538.

    Not in our library10.1128/jcm.36.2.531-538.1998

  15. 15.

    Hirabayashi Y., Oka S., Goto H., Shimada K., Kurata T., Fisher-Hoch S. P., McCormick J. B. An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis. 1988;158(4):872-875.

    Not in our library10.1093/infdis/158.4.872

  16. 16.

    Holmes G. P., McCormick J. B., Trock S. C., Chase R. A., Lewis S. M., Mason C. A., Hall P. A., Brammer L. S., Perez-Oronoz G. I., McDonnell M. K. Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990;323(16):1120-1123.

    Not in our library10.1056/nejm199010183231607

  17. 17.

    Hufert F. T., Lüdke W., Schmitz H. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch Virol. 1989;106(3-4):201-212.

    Not in our library10.1007/bf01313953

  18. 18.

    Jahrling P. B., Frame J. D., Rhoderick J. B., Monson M. H. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans R Soc Trop Med Hyg. 1985;79(3):380-384.

    Not in our library10.1016/0035-9203(85)90388-8

  19. 19.

    Jahrling P. B., Frame J. D., Smith S. B., Monson M. H. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg. 1985;79(3):374-379.

    Not in our library10.1016/0035-9203(85)90386-4

  20. 20.

    Johnson K. M., Monath T. P. Imported Lassa fever--reexamining the algorithms. N Engl J Med. 1990;323(16):1139-1141.

    Not in our library10.1056/nejm199010183231611

  21. 21.

    Kobiler D., Rice C. M., Brodie C., Shahar A., Dubuisson J., Halevy M., Lustig S. A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats. J Virol. 1999;73(12):10440-10446.

    Not in our library10.1128/jvi.73.12.10440-10446.1999

  22. 22.

    Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986;44(2):283-292.

    Not in our library10.1016/0092-8674(86)90762-2

  23. 23.

    Krasko A. G., Moshnikova A. B., Kozhich A. T., Tchikin L. D., Ivanov V. T., Vladyko A. S., Lukashevich I. S. Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1. Arch Virol. 1990;115(1-2):133-137.

    Not in our library10.1007/bf01310630

  24. 24.

    La Posta V. J., Auperin D. D., Kamin-Lewis R., Cole G. A. Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus. J Virol. 1993;67(6):3497-3506.

    Not in our library10.1128/jvi.67.6.3497-3506.1993

  25. 25.

    Lloyd G., Barber G. N., Clegg J. C., Kelly P. Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen. Lancet. 1989;2(8673):1222-1222.

    Not in our library10.1016/s0140-6736(89)91833-3

  26. 26.

    Lukashevich I. S. Generation of reassortants between African arenaviruses. Virology. 1992;188(2):600-605.

    Not in our library10.1016/0042-6822(92)90514-p

  27. 27.

    Mahdy M. S., Chiang W., McLaughlin B., Derksen K., Truxton B. H., Neg K. Lassa fever: the first confirmed case imported into Canada. Can Dis Wkly Rep. 1989;15(39):193-198.

    Not in our library

  28. 28.

    McCormick J. B., King I. J., Webb P. A., Johnson K. M., O'Sullivan R., Smith E. S., Trippel S., Tong T. C. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155(3):445-455.

    Not in our library10.1093/infdis/155.3.445

  29. 29.

    Monath T. P., Maher M., Casals J., Kissling R. E., Cacciapuoti A. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg. 1974;23(6):1140-1149.

    Not in our library10.4269/ajtmh.1974.23.1140

  30. 30.

    Monath T. P., Mertens P. E., Patton R., Moser C. R., Baum J. J., Pinneo L., Gary G. W., Kissling R. E. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg. 1973;22(6):773-779.

    Not in our library10.4269/ajtmh.1973.22.773

  31. 31.

    Morrison H. G., Bauer S. P., Lange J. V., Esposito J. J., McCormick J. B., Auperin D. D. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology. 1989;171(1):179-188.

    Not in our library10.1016/0042-6822(89)90525-4

  32. 32.

    Ruo S. L., Mitchell S. W., Kiley M. P., Roumillat L. F., Fisher-Hoch S. P., McCormick J. B. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol. 1991;72(Pt 3):549-555.

    Not in our library10.1099/0022-1317-72-3-549

  33. 33.

    Spotts D. R., Reich R. M., Kalkhan M. A., Kinney R. M., Roehrig J. T. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins. J Virol. 1998;72(12):10286-10291.

    Not in our library10.1128/jvi.72.12.10286-10291.1998

  34. 34.

    Ter Meulen J., Koulemou K., Wittekindt T., Windisch K., Strigl S., Conde S., Schmitz H. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol. 1998;36(11):3143-3148.

    Not in our library10.1128/jcm.36.11.3143-3148.1998

  35. 35.

    Vladyko A. S., Bystrova S. I., Malakhova I. V., Kunitskaia L. Ia, Lemeshko N. N., Kras'ko A. G., Kozhich A. T., Lukashevich I. S. Lokalizatsiia i predvaritel'naia kharakteristika antigennykh saitov (B-épitopov) v belke nukleokapsida virusa Lassa. Vopr Virusol. 1993;38(1):30-34.

    Not in our library

  36. 36.

    Weber E. L., Buchmeier M. J. Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology. 1988;164(1):30-38.

    Not in our library10.1016/0042-6822(88)90616-2

  37. 37.

    Wilson S. M., Clegg J. C. Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region. Virology. 1991;180(2):543-552.

    Not in our library10.1016/0042-6822(91)90068-m

  38. 38.

    Zweighaft R. M., Fraser D. W., Hattwick M. A., Winkler W. G., Jordan W. C., Alter M., Wolfe M., Wulff H., Johnson K. M. Lassa fever: response to an imported case. N Engl J Med. 1977;297(15):803-807.

    Not in our library10.1056/nejm197710132971504

  39. 39.

    ter Meulen J., Badusche M., Kuhnt K., Doetze A., Satoguina J., Marti T., Loeliger C., Koulemou K., Koivogui L., Schmitz H. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol. 2000;74(5):2186-2192.

    Not in our library10.1128/jvi.74.5.2186-2192.2000

  40. 40.

    ter Meulen J. Lassa fever: implications of T-cell immunity for vaccine development. J Biotechnol. 1999;73(2-3):207-212.

    Not in our library10.1016/s0168-1656(99)00122-4

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.